Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment
Year: 2005
Type: article
Study design: Clinical Trial
Source: Journal of Autoimmunity
Authors: Erdem Tüzün, Matthew N. Meriggioli, Julie Rowin, Huan Yang, Premkumar Christadoss
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2062338837
